Esser-Skala, Wolfgang
Segl, Marius
Wohlschlager, Therese
Reisinger, Veronika
Holzmann, Johann
Huber, Christian G.
Funding for this research was provided by:
National Foundation of Research, Technology and Development
Austrian Federal Ministry of Digital and Economic Affairs
State of Salzburg
Article History
Received: 15 May 2020
Revised: 22 June 2020
Accepted: 30 June 2020
First Online: 20 July 2020
Compliance with ethical standards
:
: Veronika Reisinger and Johann Holzmann are employees of Novartis, which provides financial support for the Christian Doppler Laboratory for Innovative Tools for Biosimilar Characterization. The salaries of Wolfgang Esser-Skala, Marius Segl, and Therese Wohlschlager are fully funded; Christian G. Huber’s salary is partly funded by the Christian Doppler Laboratory for Biosimilar Characterization. The authors declare that they have no other financial or non-financial conflict of interest.